Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6292424rdf:typepubmed:Citationlld:pubmed
pubmed-article:6292424lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C0014939lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C0030866lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C0617403lld:lifeskim
pubmed-article:6292424lifeskim:mentionsumls-concept:C0617405lld:lifeskim
pubmed-article:6292424pubmed:issue11lld:pubmed
pubmed-article:6292424pubmed:dateCreated1983-1-19lld:pubmed
pubmed-article:6292424pubmed:abstractTextTwo gamma-emitting estrogen analogues, (2R*,3S*)-1-[125I]iodo-2,3-bis(4-hydroxyphenyl)pentane ([125I]iodonorhexestrol) and (2R*,3S*)-1-[77Br]bromo-2,3-bis(4-hydroxyphenyl]pentane ([77Br]bromonorhexestrol), have been prepared by halide ion displacement on a labile trifluoromethanesulfonate derivative of a suitably protected precursor, followed by mild acid deprotection. Although halide displacement on a more stable tristrifluoromethanesulfonate derivative was successful, the basic conditions required for deprotection of this precursor resulted in destruction of the products by a base-induced spiroelimination reaction. In immature female rats, both of these halonorhexestrols demonstrated preferential uptake by the uterus that could be blocked selectively by coadministration of a large dose of unlabeled estradiol. In a double label comparison with 16 alpha-[125I]iodo-17 beta-estradiol the uterine uptake of [77Br]bromonorhexestrol was notably less selective. Stability studies in vitro and in vitro have indicated that both iodo- and bromonorhexestrol are quite labile, and this lability compromises the selectivity of their uptake by estrogen target tissues in vivo. p-Hydroxyphenethyl halides are known to be unusually prone to a base-catalyzed solvolysis, via cyclization of the phenolate to a spirocyclohexadienone intermediate. This unusual solvolytic mechanism may contribute to the lability of these halonorhexestrols in vivo.lld:pubmed
pubmed-article:6292424pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:languageenglld:pubmed
pubmed-article:6292424pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:citationSubsetIMlld:pubmed
pubmed-article:6292424pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6292424pubmed:statusMEDLINElld:pubmed
pubmed-article:6292424pubmed:monthNovlld:pubmed
pubmed-article:6292424pubmed:issn0022-2623lld:pubmed
pubmed-article:6292424pubmed:authorpubmed-author:WelchM JMJlld:pubmed
pubmed-article:6292424pubmed:authorpubmed-author:Katzenellenbo...lld:pubmed
pubmed-article:6292424pubmed:authorpubmed-author:McElvanyK DKDlld:pubmed
pubmed-article:6292424pubmed:authorpubmed-author:LandvatterS...lld:pubmed
pubmed-article:6292424pubmed:issnTypePrintlld:pubmed
pubmed-article:6292424pubmed:volume25lld:pubmed
pubmed-article:6292424pubmed:ownerNLMlld:pubmed
pubmed-article:6292424pubmed:authorsCompleteYlld:pubmed
pubmed-article:6292424pubmed:pagination1307-12lld:pubmed
pubmed-article:6292424pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:meshHeadingpubmed-meshheading:6292424-...lld:pubmed
pubmed-article:6292424pubmed:year1982lld:pubmed
pubmed-article:6292424pubmed:articleTitle(2R*,3S*)-1-[125I]Iodo-2,3-bis(4-hydroxyphenyl)pentane ([125I]iodonorhexestrol) and (2R*,3S*)-1-[77Br]Bromo-2,3-bis(4-hydroxyphenyl)pentane ([77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo.lld:pubmed
pubmed-article:6292424pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6292424pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:6292424pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6292424pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:6292424lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6292424lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6292424lld:pubmed